Gary A Lyons Brickell Biotech, Inc. (BBI) insider trading activity

BBI Quotes by TradingView

Gary A Lyons is Director of Brickell Biotech, Inc.. Currently has a direct ownership of 18,762 shares of BBI, which is worth approximately $33,021. The most recent transaction as insider was on Dec 31, 2020, when has been sold 5,967 shares (Common Stock) at a price of $0.78 per share, resulting in proceeds of $4,654. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 18.8K
0% 3M change
0% 12M change
Total Value Held $33,021

GARY A LYONS Transaction History

Date Transaction Value Shares Traded Shares Held Form
Dec 31 2020
SELL
Payment of exercise price or tax liability
$4,654 $0.78 p/Share
5,967 Reduced 24.13%
18,762 Common Stock

Also insider at

HGEN
HUMANIGEN, INC Healthcare
Director
NBIX
NEUROCRINE BIOSCIENCES INC Healthcare
Director
TVTX
Travere Therapeutics, Inc. Healthcare
RIGL
RIGEL PHARMACEUTICALS INC Healthcare
ELDN
Eledon Pharmaceuticals, Inc. Healthcare
Director
GAL

Gary A Lyons

Director
South San Francisco, CA

Track Institutional and Insider Activities on BBI

Follow Brickell Biotech, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells BBI shares.

Notify only if

Insider Trading

Get notified when an Brickell Biotech, Inc. insider buys or sells BBI shares.

Notify only if

News

Receive news related to Brickell Biotech, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on BBI